disease (7), and Guillain-Barre syndrome (8). The association between H. pylori and these extragastric disorders is supported by the finding that they resolve on eradication of H. pylori. Although the basic mechanisms by which H. pylori infection in the stomach mediates the above-mentioned disorders is unclear, it has been suggested that they result from the inflammatory process elicited by H. pylori in the stomach and the subsequent systemic consequences. The most commoncause of iron deficiency anemia (IDA) is insufficient iron intake, blood loss from the intestinal tract, poor absorption, and malabsorption or diversion of iron in the reticulo-endothelial system. Moreover, H. pylori infection as a cause of refractory IDA has been reported by Dufour et al (5) : Based on findings that recovery from IDA can occur after H. pylori eradication therapy and without supplemental iron, it has been suggested that this bacterium actually blocks iron metabolism. Since this initial report, the several supplementary trials by clinical investigation have been performed and the relation between H. pylori infection and IDA has been confirmed (9, 10). In a double-blind controlled trial, H. pylori eradication in 10 to 17-year-olds with IDAresulted in a significant increase in serum hemoglobin level at eight weeks post-therapy, compared with a control group (individuals with IDA and not receiving H. pylori eradication therapy) (1 1). In the control group, there was no change in the hematologic profile and iron stores, and anemia was refractory to the iron treatment. 
